HIV Vaccine Might
Be Available in 2021 Scientists describe the current
possibility of an HIV vaccine as
“perhaps one of the most optimistic
moments we have been in" since 1984. Three experimental
HIV vaccine trials are set to
enter the final testing stages. Dr. Susan Buchbinder, San Francisco Department of Public Health, via NBC News One of the trial vaccines,
HVTN 702, is based on an earlier
vaccine that showed a 30% effectiveness rate. A second trial vaccine, Imbokodo,
is being tested on 2,600 women
from five southern African nations. The third trial, Mosaico,
will be tested in the U.S., Europe
and Latin America on
3,800 gay men and trans people. Dr. Susan Buchbinder, San Francisco Department of Public Health, via NBC News Even if the trials fail, public
health officials point to the
effectiveness of prevention treatments,
such as PrEP, to halt the spread of HIV.